Back to search results

Improving Tobacco Treatment for Veterans with Serious Mental Illness

This study is looking at ways to help mental health providers at the VA Maryland Health Care System better support Veterans with serious mental illness (SMI) who want to quit smoking. Many Veterans with SMI smoke, even though safe and effective medications like nicotine replacement therapies (lozenge, gum, patch, nasal spray), bupropion, and varenicline are available. The study will use a method called "multi-component facilitation" to help providers overcome challenges in offering these treatments. Success will be measured by tracking how well this facilitation works over 12 months, and through interviews. This study is for providers and Veterans at specific VA Maryland clinics. The current status of the study is unclear.

Study design
This interventional study plans to enroll 65 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track implementation activities weekly for 12 months and conduct interviews 12 months after implementation begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07455526

Facilitation to Increase Tobacco Treatment

Not Yet Recruiting
NAAll AgesInterventionalHealth services
VA Office of Research and Development
~65 participants
Updated 2026-03-06 on ClinicalTrials.gov
What's tested:Multi-component facilitation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Semi-structured, one-on-one interviews
Measured over 12 months after start of implementation at each site
+1 more outcome measured

Conditions

Serious Mental Illness
Tobacco Use Disorder

Explore related trials

Serious mental illnessTobacco Use Disorder

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Corinne N Kacmarek, PhD · PRINCIPAL_INVESTIGATOR · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Who to contact

Corinne N Kacmarek, PhD
[email protected]
(410) 340-0727
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

VA Maryland Health Care System patient care providers serving Veterans in Critical Time Intervention, Psychosocial Rehabilitation and Recovery Center, Mental Health Integrative Case Management, or outpatient psychiatry clinics
Had an appointment in VA Maryland Health Care System, Critical Time Intervention, Psychosocial Rehabilitation and Recovery Center, Mental Health Integrative Case Management, or outpatient psychiatry clinics in the last 30 days
Diagnosed with a serious mental illness
Positive tobacco use screen
Appointment scheduled with an outpatient psychiatric prescriber in the next 30 days
Of note, study staff are not directly recruiting Veterans for this implementation intervention component
All Veterans actively enrolled in VAMHCS medical facilities with at least one encounter during a given period with available smoking health factor data
Of note, study staff are not directly recruiting veterans for this data analysis

Exclusion

None
Active prescription for bupropion, varenicline, or any nicotine replacement therapy

What this trial measures

  • Semi-structured, one-on-one interviews12 months after start of implementation at each site

    Acceptability and feasibility: Interviews will gauge provider satisfaction with the implementation strategy (acceptability) and provider perceptions of the actual fit of the implementation strategy with the clinical setting (feasibility). This qualitative data will be analyzed for common themes. The number of providers endorsing each theme will be quantified.

  • Implementation trackerWeekly for the duration of the implementation at each site (12 months)

    Based on observation, the investigators will track provider attendance at trainings (number of providers attending divided by total number of eligible providers) and number of academic detailing sessions completed per provider (minimum = 1, maximum = 3) in an excel spreadsheet as benchmarks of feasibility to inform refinements to the implementation strategy.